2023: The US Patent Office has issued a patent to DNA Polymerase Technology for Taq D732N, a single mutant of Taq that can catalyze RT-PCR, RT-LAMP, faster PCR, and improved PCR for food safety.  Find the product under our trade name, OmniTaq 2. 
For more details, see our refereed paper:  A Single Amino Acid Change to Taq DNA Polymerase Enables Faster PCR, Reverse Transcription and Strand-Displacement.  Front. Bioeng. Biotechnol. 2021 8:553474.

2020: PEC-P and "Rescue PCR" found to be useful tools for studying "aged, degraded, and/or low copy number DNA samples compromised by PCR inhibitors."

2020: Klentaq1 aids in development of bisulfite PCR-LDR-qPCR assay for breast cancer detection.

2019: Development of a direct reverse-transcription quantitative PCR (dirRT-qPCR) assay for clinical Zika diagnosis

2019: Vanderbilt Researchers detect SNP markers for antimalarial resistance using OmniTaq 3.

2017: A fast and accurate method of detecting Aleutian mink disease virus in blood and tissues of chronically infected mink

2017 and 2019:  OmniKlentaq LA aids in the development of Long-Adapter Single-Strand Oligonucleotide (LASSO) probes: 2017 and 2019.

2015: National Institute of Justice Success Story: Addressing a Key Challenge for PCR-Based Forensic Tests

2014: Lab-on-a-chip technology for Malaria detection from whole blood using OmniKlentaq and PEC-1

2013: OmniKlentaq-LA beats out 8 other PCR enzymes on old bones

2008: DNA Polymerase Technology's scientist, Dr. Milko Kermekchiev, named Inventor of the Year.

2002: "Small lab graduates from incubator to building with space enough to share"